EyePoint Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of EyePoint Pharmaceuticals using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-07 | $-0.54 | $-0.55 | 1.82 % |
Jun 2024 | 2024-08-07 | $-0.58 | $-0.52 | -11.5 % |
Mar 2024 | 2024-05-08 | $-0.55 | $-0.42 | -30.9 % |
Dec 2023 | 2024-03-07 | $-0.33 | $-0.49 | 32.6 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-07 | $10.52M | $9.93M | 5.98 % |
Jun 2024 | 2024-08-07 | $9.48M | $9.59M | -1.18 % |
Mar 2024 | 2024-05-08 | $11.68M | $9.92M | 17.8 % |
Dec 2023 | 2024-03-07 | $14.03M | $8.90M | 57.6 % |
EyePoint Pharmaceuticals ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 7, 2024 for Q3.
EyePoint Pharmaceuticals ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 7, 2024 for Q3 and the Actual EPS was $-0.54, which beat the estimate of $-0.55.
EyePoint Pharmaceuticals ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 7, 2024 for Q3 and the Actual EPS was {{actualEPS}}, which beat the estimate of {{estEPS}}.
Browse earnings estimates, EPS, and revenue on all stocks.